⌘K

Home/Filings/4/0001209191-20-002445

4//SEC Filing

ANSARI ABID 4

Accession 0001209191-20-002445

CIK 0001357874other

View on SEC.gov Company Profile

Filed

Jan 7, 7:00 PM ET

Accepted

Jan 8, 8:23 AM ET

Size

11.0 KB

Accession

0001209191-20-002445

Insider Transaction Report

Form 4

Period: 2020-01-06

PRECISION BIOSCIENCES INCDTIL

Chief Financial Officer

Transactions

Exercise/Conversion
Common Stock
2020-01-06$1.20/sh+17,566$21,079→ 121,211 total
Exercise/Conversion
Employee Stock Options (Right to Buy)
2020-01-06−17,566→ 26,351 total
Exercise: $1.20Exp: 2026-08-10→ Common Stock (17,566 underlying)
Exercise/Conversion
Common Stock
2020-01-06$1.18/sh+2,634$3,108→ 123,845 total
Exercise/Conversion
Employee Stock Option (Right to Buy)
2020-01-06−2,634→ 4,392 total
Exercise: $1.18Exp: 2027-03-23→ Common Stock (2,634 underlying)

Footnotes (2)

[F1]The option vested as to 25% of the underlying shares on August 11, 2017 and vests in equal installments at the end of each successive three-month period over the 36 months following such date.
[F2]The option vested as to 25% of the underlying shares on March 24, 2018 and vests in equal installments at the end of each successive three-month period over the 36 months following such date.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

PRECISION BIOSCIENCES INC

CIK 0001357874

Entity typeother

Related Parties

1

filerCIK 0001770149

Filing Metadata

Form type: 4
Filed: Jan 7, 7:00 PM ET
Accepted: Jan 8, 8:23 AM ET
Size: 11.0 KB

View on SEC.gov